Is Protalix BioTherapeutics Inc (AMEX: PLX) Hit More of the Losses Given A -100.0% Dip From High?

During the last session, Protalix BioTherapeutics Inc (AMEX:PLX)’s traded shares were 0.47 million, with the beta value of the company hitting -0.21. At the end of the trading day, the stock’s price was $1.55, reflecting an intraday loss of -2.52% or -$0.04. The 52-week high for the PLX share is $3.10, that puts it down -100.0 from that peak though still a striking 47.1% gain since the share price plummeted to a 52-week low of $0.82. The company’s market capitalization is $123.40M, and the average trade volume was 975.74K shares over the past three months.

Protalix BioTherapeutics Inc (AMEX:PLX) trade information

Protalix BioTherapeutics Inc (PLX) registered a -2.52% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -2.52% in intraday trading to $1.55, hitting a weekly high. The stock’s 5-day price performance is -6.06%, and it has moved by -49.51% in 30 days. Based on these gigs, the overall price performance for the year is 33.62%.

While earnings are projected to return 612.50% in 2025.

PLX Dividends

Protalix BioTherapeutics Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

The next largest institutional holding, with 0.8 million shares, is of RENAISSANCE TECHNOLOGIES LLC’s that is approximately 1.1016% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $0.94 million.

Also, the Mutual Funds coming in first place with the largest holdings of Protalix BioTherapeutics Inc (PLX) shares are Unified Series Trust-AUER GROWTH FUND and Bridgeway Funds, Inc.-Ultra-Small Company Market Fund . Data provided on Mar 31, 2025 indicates that Unified Series Trust-AUER GROWTH FUND owns about 200.0 shares. This amounts to just over 0.25 percent of the company’s overall shares, with a $0.31 million market value. The same data shows that the other fund manager holds slightly less at 180.0, or about 0.23% of the stock, which is worth about $0.28 million.